About

Director since July 2020. Former EVP of Finance and Strategy of Royalty Pharma Management. Serves on the boards of AnaptysBio, Theravance Biopharma and Maravai LifeSciences.

Roles

4D Molecular Therapeutics, Inc.
Director · Current role
2020–present

Director Compensation

FY 2025
Fees earned or paid in cash
$65,000
Option awards
$70,000
Total
$135,000

Also at 4D Molecular Therapeutics, Inc.

Related

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.